Cargando…
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
BACKGROUND: The RTOG 94-13 trial has provided evidence that patients with high risk prostate cancer benefit from an additional radiotherapy to the pelvic nodes combined with concomitant hormonal ablation. Since lymphatic drainage of the prostate is highly variable, the optimal target volume definiti...
Autores principales: | Ganswindt, Ute, Paulsen, Frank, Corvin, Stefan, Eichhorn, Kai, Glocker, Stefan, Hundt, Ilse, Birkner, Mattias, Alber, Markus, Anastasiadis, Aristotelis, Stenzl, Arnulf, Bares, Roland, Budach, Wilfried, Bamberg, Michael, Belka, Claus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190164/ https://www.ncbi.nlm.nih.gov/pubmed/16048656 http://dx.doi.org/10.1186/1471-2407-5-91 |
Ejemplares similares
-
Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study
por: Ganswindt, U, et al.
Publicado: (2006) -
[(68)Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
por: Gehler, Barbara, et al.
Publicado: (2009) -
Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008) -
Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma
por: Budach, W, et al.
Publicado: (2002) -
Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments
por: Kantz, Steffi, et al.
Publicado: (2015)